Tag Archives: CEO Jim Greenwood

BIO President & CEO Presents Dr. Cohen With Lifetime Achievement Award

Jim-and-Cohen

Last week, Jim Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), attended the 10th Annual BayBio Pantheon Ceremony, where he presented Dr. Stanley N. Cohen with the BayBio Lifetime Achievement DiNA Award for his contributions to making a transformative difference within the life science industry. The event was attended by more than 600 biotechnology innovators, entrepreneurs, investors, elected officials and policy leaders. Dr. Cohen’s groundbreaking work with Dr. Herbert Boyer is widely credited Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Congratulations to Gevo on the Construction of its New Demonstration Paraxylene Plant

Gevo

On Monday, August 26, 2013, Gevo, Inc., the world’s only commercial producer of bio-isobutanol, held a ribbon cutting ceremony for its demonstration-scale paraxylene plant in Silsbee, Texas.  BIO’s own CEO Jim Greenwood attended the ribbon cutting ceremony and had this to say: “Industrial biotechnology companies such as Gevo show the true scope and reach of American innovation and ingenuity. After you visit these companies, after you see how entrepreneurs like Gevo CEO Pat Gruber and his Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO CEO Jim Greenwood in Washington Business Journal

JimGreenwood

Jeff Porro’s recent article, “Speaking to Rise”, in the Washington Business Journal features an interview with Biotechnology Industry Organization (BIO) President and CEO, Jim Greenwood. Jim will be giving the keynote address for this year’s BIO International Convention in DC June 27-30, and suggests that the best way to discuss difficult topics like biotechnology is to “put a human face on the subject matter” and to make the material relatable to the audience. When addressing Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIOtech NOW: The Role of Intellectual Property in Global Health

The Role of Intellectual Property in Global Health BIO is committed to increase access to biologic medicines for patients throughout the world.  As BIO President and CEO Jim Greenwood said last year when announcing our policy statement on Options for Increasing Access to Medicines in the Developing World, “We believe that the goals of increasing access to medicines, respecting intellectual property rights, and maintaining commercial viability are mutually supportive.” While there are frequent misguided calls Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,